Quality of oral anticoagulation: An observation study;Qualität der oralen langzeitantikoagulation: Eine beobachtungsstudie

Praxis

Volumn 92, Issue 42, 2003, Pages 1769-1773

  Turk, A ^a   Sidler, P ^a   Buhler H ^a   Christen, S ^a  

^a Stadtspital Waid   (Switzerland)

Author keywords

Indication; International normalised ration; Oral anticoagulation; Quality

Indexed keywords

EID: 80051671153     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/0369-8394.92.42.1769     Document Type: Article

References (21)

1. The European Atrial Fibrillation Trial Study Group: Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med, 333(1), 5-10, 1995.
2. Stäubli M.: Komplikationen medizinischer Interventionen. Schweizerische Ärztezeitung, 82(25), 1331-1338, 2001.
3. Ansell J., Hirsh J., Dalen J., Bussey H., Anderson D., Poller L., Jakobson A., Deykin D., Matchar D.: Managing oral anticoagulant therapy. Chest, 119, 22S-38S, 2001. (Pubitemid 32154193)
4. Poller L., Shiach C.R., MacCallum P.K., Johansen A.M., Münster A.M., Magalha&tild;es A., Jespersen J.: Multicentre randomised study of computerised anticoagulant dosage. Lancet, 352, 1505-1509, 1998. (Pubitemid 28512926)
5. Hull R., Hirsh J., Jay R.: Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med, 307, 1676-1681, 1982. (Pubitemid 13206049)
6. Turpie A.G.G., Gunstensen J., Hirsh J.: Randomized comparison of two intensities of oral anticoagulant therapy after tissue heart valve replacement. Lancet,1,1242-1245, 1988.
7. Saor J.N., Sieck J.O., Mamo L.A.R.: Trial of different intensities of anticoagulation in patients with prostathic heart valves. N Engl J Med, 322, 428-432, 1990. (Pubitemid 20059511)
8. Altman R., Rouvier J., Gurfinkel E.: Comparison of two levels of anticoagulant therapy in patients with substitute heart valves. J Thorac Cardiovasc Surg, 101, 427-431, 1991.
9. Hirsch J., Dalen J., Anderson D., Poller L., Bussey H., Ansell J., Deykein D.: Oral Anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest, 119, 8S-21S, 2001. (Pubitemid 32154192)
10. CAPRIE Steering Committee. A randomised, blinded, trial of clopidorel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet, 348, 1329-1339, 1996.
11. Yermiahu T., Arbelle J.E., Shwartz D., Levy Y., Tractinsky N., Porath A.: Quality assessment of oral anticoagulant treatment in the Beer-Sheba district. Int J Qual Health Care, 13(3), 209-213, 2001. (Pubitemid 32677172)
12. Holm T., Deutch S., Lassen J.F., Jastrup B., Husted S.E., Heickendorff L.: Prospective evaluation of the quality of oral anticoagulation management in an outpatient clinic and in general practices. Thromb Res, 105(2), 103-108, 2002. (Pubitemid 34214924)
13. Manotti C., Moia M., Palareti G., Pengo V., Ria L., Dettori A.: Effect of computer- aided management on the quality of treatment in anticoagulated patients: a prospective, randomized, multicenter trial of APROAT (Automated Program for Oral Anticoagulant Treatment). Haematologica, 86, 1060-1070, 2001. (Pubitemid 33031872)
14. Caliezi C., Waber M., Pfiffner D., Saner H., Lämmle B., Wuillemin W.A.: Patienten-Selbstkontrolle der oralen Antikoagulation mit CoaguChek(r). Schweiz Med Wochenschr, 130, 916-923, 2001.
15. Sickles J., Elston-Lafata J., Ansell J.: Point-of-care testing in coagulation and hemostasis: implications for patient management. Dis Manage Health Outcomes, 6, 291-301, 1999.
16. Cromheecke M., Levi M., Colly., de Mol B., Prins M., Hutten B., Mak R., Keyzers K., Büller H.: Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet, 356, 97-102, 2000.
17. Copland M., Walker I., Tait R.: Oral antikoagulation and hemorrhagic complications in an elderly population with atrial fibrillation. Arch Intern Med, 161(17), 2125-2128, 2001.
18. Fihn S., Callahan C., Martin D., McDonell M., Henikoff J., White R.: The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics. Ann Intern Med, 124(11), 970-979, 1996.
19. Schulman S., Henriksson K.: Interaction of ibuprofen and warfarin on primary haemostasis. Br J Rheumatol, 28(1), 46-49, 1989. (Pubitemid 19107401)
20. Dale J., Myhre E., Loew D.: Bleeding during acetylsalicylic acid and anticoagulant therapy in patients with reduced platelet reactivity after aortic valve replacement. Am Heart J, 99(6), 746-752, 1980.
21. Jackson M., Clagett G.: Antithrombotic therapy in perpheral arterial occlusive disease. Chest, 119, 283S-299S, 2001. (Pubitemid 32154206)